Laxmi A Kondapalli

No ORCID on file · 4 papers in corpus
nonrandomized-trial 2025
Prolonged oral GnRH-antagonist administration before euploid embryo transfer in patients with endometriosis: a prospective randomized pilot non-inferiority trial
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2025.105125

RESEARCH QUESTION: Is oral administration of a gonadotrophin releasing hormone (GnRH) antagonist for 2 months before euploid embryo transfer in patients with endometriosis non-inferior to intramuscular administration of a long-acting GnRH a…

2024
PROLONGED ORAL GnRH ANTAGONIST ADMINISTRATION PRIOR TO EUPLOID EMBRYO TRANSFER (ET) IN ENDOMETRIOSIS (ENDO) PATIENTS: A PROSPECTIVE RANDOMIZED NON-INFERIORITY TRIAL
·doi:10.1016/j.fertnstert.2024.07.381
observational 2016
Natural cycle IVF reduces the risk of low birthweight infants compared with conventional stimulated IVF
Human reproduction (Oxford, England) ·doi:10.1093/humrep/dew024

STUDY QUESTION: Are perinatal outcomes improved in singleton pregnancies resulting from fresh embryo transfers performed following unstimulated/natural cycle IVF (NCIVF) compared with stimulated IVF? SUMMARY ANSWER: Infants conceived by un…

2016
Prolonged administration of GnRH agonist (GnRHa) prior to embryo transfer (ET) in endometriosis (ENDO) and integrin (INT)negative patients: the impact of freeze-all cycles
·doi:10.1016/j.fertnstert.2016.07.775